Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Jim Cramer on Abbott Laboratories (ABT): ‘Big Position For The Trust’

We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks.

Jim Cramer, host of Mad Money, recently offered some important advice on how young people should approach investing and managing their money. He emphasized that the first and most important step for anyone is to invest. Cramer pointed out that investing is the only way to secure financial freedom in the long term. He then stated:

“Before you can start investing, you need to pay off the foreign credit card… No matter how much money you rack up in the stock market, if you’re carrying a balance on your credit cards, then it’s going to eat your returns.”

READ ALSO 10 Stocks on Jim Cramer’s Radar and 17 Best Stocks for Kids According to Jim Cramer

Cramer then shared a few lessons specifically tailored for young investors. He explained that the first piece of advice is valuable to people of all ages. His advice was that young people should save money. He noted that the stock market can actually serve as a tool to help people save by forcing them to set aside a portion of their paycheck that they might otherwise spend. He then added:

“Second lesson for young investors, this is a much more targeted piece of advice: While you’re still young, you can afford to take a lot more risks than say a gray beard like myself.”

Finally, Cramer stressed that it is never too early to begin planning for retirement. He recommended taking full advantage of any employer-sponsored 401(k) plan, especially if the employer matches contributions. He also urged young investors to consider contributing to a Roth IRA, which he described as an ideal option for those early in their careers.

“Here’s the bottom line: For young people just outta college investing is a great way to trick yourself into saving money you might otherwise spend. Beyond that, remember, when you’re young, you can afford to take a lot more risk with your portfolio and it’s never too soon to start contributing to your 401k or IRA.”

Our Methodology

For this article, we compiled a list of 10 stocks that were discussed by Jim Cramer during the episode of Mad Money aired on January 24. We listed the stocks in ascending order of their hedge fund sentiment as of the third quarter, which was taken from Insider Monkey’s database of 900 hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

An operating room with a doctor monitoring a patient’s vital signs during surgery with a medical device.

Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Holders: 63

Abbott Laboratories (NYSE:ABT) was mentioned during the episode. Here’s what Mad Money’s host had to say:

“Yeah, Abbott was, was along with Intuitive Surgical, one of the stars of the… JPMorgan Healthcare conference last week. I’m glad I went out there… I went and really kicked the tires on Abbott and we loved what we saw. Robert Ford is doing a remarkable job and the stock is up in a straight line at $125. I can’t recommend anything on a straight line. But if it pulls back a couple of bucks, though, it’s good because this should be one of the great pharma stories because it’s got the best growth in device and pharmaceuticals. I think it’s great. And the market finally seemed to realize what Robert Ford and I believe, Abbott is a great company. Big position for the trust.”

Abbott Laboratories (NYSE:ABT) is a healthcare firm focused on the research, development, manufacturing, and marketing of a wide variety of healthcare products.

Overall ABT ranks 2nd on our list of the stocks Jim Cramer recently shed light on. While we acknowledge the potential of ABT as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than ABT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article was originally published at Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!